Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now

"The greatest wealth is health."         - Virgil


      Advertisement

IGA NEPHROPATHY side effect

What is IGA NEPHROPATHY ?
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with IGA NEPHROPATHY

AZULFIDINE  CADUET  DOXAZOSIN  MYCOPHENOLATE  NORDITROPIN  OLMESARTAN  PROGRAF  REMICADE  


IGA NEPHROPATHY : Remicade Side Effects Report #5677114-1
Physician from BELGIUM reported REMICADE problem on Mar 14, 2008. Male patient, 65 years of age, weighting 202.8 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . REMICADE dosage: unknown. During the same period patient was treated with ARCOXIA, ZYLORIC. Patient was hospitalized. Patient recovered.

IGA NEPHROPATHY : Remicade Side Effects Report #5634378-8
REMICADE problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Female patient was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, infusion related reaction, . REMICADE dosage: unknown. Patient recovered.

IGA NEPHROPATHY : Remicade Side Effects Report #5634379-X
Health Professional from UNITED STATES reported REMICADE problem on Feb 11, 2008. Male patient, 38 years of age, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . REMICADE dosage: unknown. Patient recovered.

IGA NEPHROPATHY : Remicade Side Effects Report #5636614-0
REMICADE problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Male patient, 38 years of age, weighting 190.0 lb, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, immunoglobulins increased, . REMICADE dosage: unknown. Patient recovered.

IGA NEPHROPATHY : Caduet Side Effects Report #5643610-6
Physician from UNITED STATES reported CADUET problem on Feb 20, 2008. Male patient, weighting 296.1 lb, was treated with CADUET. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, renal impairment, . CADUET dosage: unknown. Patient recovered.

IGA NEPHROPATHY : Norditropin Side Effects Report #5599956-3
NORDITROPIN problem was reported by a Physician from JAPAN on Jan 18, 2008. Male patient, weighting 32.63 lb, was diagnosed with small for dates baby and was treated with NORDITROPIN. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . NORDITROPIN dosage: unknown. Patient was hospitalized. Patient recovered.

IGA NEPHROPATHY : Remicade Side Effects Report #5607297-0
Physician from UNITED STATES reported REMICADE problem on Jan 24, 2008. Female patient was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . REMICADE dosage: unknown. Patient recovered.

IGA NEPHROPATHY : Mycophenolate Side Effects Report #5541865-X
MYCOPHENOLATE MOFETIL problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Nov 27, 2007. Female patient was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: iga nephropathy, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with RAPAMUNE, SANDIMMUNE, PROGRAF, STEROID NOS. Patient recovered.

IGA NEPHROPATHY : Azulfidine Side Effects Report #5583348-7
Health Professional from JAPAN reported AZULFIDINE EN problem on Dec 27, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, platelet count decreased, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with AMLODIN, SOLETON, OLMETEC. Patient was hospitalized. Patient recovered.

IGA NEPHROPATHY : Olmesartan Side Effects Report #5589402-8
OLMESARTAN MEDOXOMIL problem was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with hypertension, rheumatoid arthritis and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, infection, lung neoplasm malignant, nephrotic syndrome, platelet count decreased, rheumatoid arthritis, thrombocytopenia, . OLMESARTAN MEDOXOMIL dosage: 20 MG (10 MG, 2 IN 1 D), PER ORAL. During the same period patient was treated with AZULFIDINE EN, SOLETON, AMLODIN. Patient was hospitalized. Patient recovered.

IGA NEPHROPATHY : Azulfidine Side Effects Report #5536243-3
Physician from JAPAN reported AZULFIDINE EN problem on Nov 20, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, thrombocytopenia, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with AMLODIN, SOLETON, OLMETEC. Patient was hospitalized. Patient recovered.

IGA NEPHROPATHY : Olmesartan Side Effects Report #5557382-7
OLMESARTAN MEDOXOMIL problem was reported by a Consumer or non-health professional from JAPAN on Nov 27, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with hypertension and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, thrombocytopenia, . OLMESARTAN MEDOXOMIL dosage: 20 MG (10 MG,2 IN 1 D), PER ORAL. During the same period patient was treated with AZULFIDINE EN, SOLETON. Patient was hospitalized. Patient recovered.

IGA NEPHROPATHY : Azulfidine Side Effects Report #5577306-6
Health Professional from JAPAN reported AZULFIDINE EN problem on Dec 14, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, platelet count decreased, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with AMLODIN, SOLETON, OLMETEC. Patient was hospitalized. Patient recovered.

IGA NEPHROPATHY : Olmesartan Side Effects Report #5581204-1
OLMESARTAN MEDOXOMIL problem was reported by a Consumer or non-health professional from JAPAN on Dec 14, 2007. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with hypertension, rheumatoid arthritis and was treated with OLMESARTAN MEDOXOMIL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, lung neoplasm malignant, nephrotic syndrome, platelet count decreased, rheumatoid arthritis, . OLMESARTAN MEDOXOMIL dosage: 20 MG (10 MG, 2 IN 1 D), PER ORAL. During the same period patient was treated with AZULFIDINE EN, SOLETON, AMLODIN. Patient was hospitalized. Patient recovered.

IGA NEPHROPATHY : Azulfidine Side Effects Report #5530968-1
Physician from JAPAN reported AZULFIDINE EN problem on Nov 20, 2007. Male patient, weighting 132.3 lb, was diagnosed with rheumatoid arthritis, hypertension and was treated with AZULFIDINE EN. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis membranous, iga nephropathy, nephrotic syndrome, thrombocytopenia, . AZULFIDINE EN dosage: unknown. During the same period patient was treated with SOLETON, OLMETEC, AMLODIN. Patient was hospitalized. Patient recovered.

IGA NEPHROPATHY : Remicade Side Effects Report #5634377-6
REMICADE problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Female patient was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, iga nephropathy, infusion related reaction, . REMICADE dosage: unknown. During the same period patient was treated with RHEUMATREX. Patient recovered.

IGA NEPHROPATHY : Doxazosin Side Effects Report #5530958-9
Consumer or non-health professional from JAPAN reported DOXAZOSIN MESYLATE problem on Nov 20, 2007. Male patient, weighting 130.1 lb, was diagnosed with hypertension and was treated with DOXAZOSIN MESYLATE. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, hypotension, iga nephropathy, . DOXAZOSIN MESYLATE dosage: unknown. During the same period patient was treated with OLMETEC, SEVOFLURANE, PROPOFOL, VECURONIUM BROMIDE, NITROUS OXIDE, OXYGEN, BREDININ, PREDNISOLONE. Patient recovered.

IGA NEPHROPATHY : Prograf Side Effects Report #5533879-0
PROGRAF problem was reported by a Physician from JAPAN on Nov 13, 2007. Female patient, 16 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: complications of transplanted kidney, haematuria, iga nephropathy, proteinuria, upper respiratory tract inflammation, . PROGRAF dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, SIMULECT, RITUXIMAB. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about IGA NEPHROPATHY side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about IGA NEPHROPATHY